Literature DB >> 28501330

Virus entry and replication in the brain precedes blood-brain barrier disruption during intranasal alphavirus infection.

Matthew D Cain1, Hamid Salimi1, Yongfeng Gong1, Lihua Yang1, Samantha L Hamilton1, James R Heffernan1, Jianghui Hou1, Mark J Miller2, Robyn S Klein3.   

Abstract

Viral infections of the central nervous system (CNS) are often associated with blood-brain barrier (BBB) disruption, yet the impact of virus replication and immune cell recruitment on BBB integrity are incompletely understood. Using two-photon microscopy, we demonstrate that Venezuelan equine encephalitis virus (VEEV) strain TC83-GFP, a GFP expressing, attenuated strain with a G3A mutation within the 5' UTR that is associated with increased sensitivity to type I interferons (IFNs), does not directly impact BBB permeability. Following intranasal infection of both wild-type and IFN-induced protein with tetratricopeptide repeats 1 (IFIT1)-deficient mice, which fail to block TC83-specific RNA translation, virus spreads to the olfactory bulb and cortex via migration along axonal tracts of neurons originating from the olfactory neuroepithelium. Global dissemination of virus in the CNS by 2days post-infection (dpi) was associated with increased BBB permeability in the olfactory bulb, but not in the cortex or hindbrain, where permeability only increased after the recruitment of CX3CR1+ and CCR2+ mononuclear cells on 6 dpi, which corresponded with tight junction loss and claudin 5 redistribution. Importantly, despite higher levels of viral replication, similar results were obtained in IFIT1-deficient mice. These findings indicate that TC83 gains CNS access via anterograde axonal migration without directly altering BBB function and that mononuclear and endothelial cell interactions may underlie BBB disruption during alphavirus encephalitis.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28501330      PMCID: PMC5694394          DOI: 10.1016/j.jneuroim.2017.04.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  37 in total

1.  Chapter 16. Two-photon microscopy and multidimensional analysis of cell dynamics.

Authors:  Bernd H Zinselmeyer; John Dempster; David L Wokosin; Jonathan J Cannon; Robert Pless; Ian Parker; Mark J Miller
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

2.  Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.

Authors:  Aaron T Phillips; Amber B Rico; Charles B Stauft; Sean L Hammond; Tawfik A Aboellail; Ronald B Tjalkens; Ken E Olson
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

3.  A viral RNA structural element alters host recognition of nonself RNA.

Authors:  Jennifer L Hyde; Christina L Gardner; Taishi Kimura; James P White; Gai Liu; Derek W Trobaugh; Cheng Huang; Marco Tonelli; Slobodan Paessler; Kiyoshi Takeda; William B Klimstra; Gaya K Amarasinghe; Michael S Diamond
Journal:  Science       Date:  2014-01-30       Impact factor: 47.728

4.  Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis.

Authors:  Alexandra Schäfer; Alan C Whitmore; Jennifer L Konopka; Robert E Johnston
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

5.  Propagation, quantification, detection, and storage of West Nile virus.

Authors:  James D Brien; Helen M Lazear; Michael S Diamond
Journal:  Curr Protoc Microbiol       Date:  2013-11-05

6.  Filament organization revealed in platinum replicas of freeze-dried cytoskeletons.

Authors:  J E Heuser; M W Kirschner
Journal:  J Cell Biol       Date:  1980-07       Impact factor: 10.539

7.  Venezuelan equine encephalitis virus in Iquitos, Peru: urban transmission of a sylvatic strain.

Authors:  Amy C Morrison; Brett M Forshey; Desiree Notyce; Helvio Astete; Victor Lopez; Claudio Rocha; Rebecca Carrion; Cristhiam Carey; Dominique Eza; Joel M Montgomery; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2008-12-16

8.  Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals.

Authors:  Brian P Daniels; David W Holman; Lillian Cruz-Orengo; Harsha Jujjavarapu; Douglas M Durrant; Robyn S Klein
Journal:  MBio       Date:  2014-08-26       Impact factor: 7.867

9.  The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity.

Authors:  Jonathan J Miner; Brian P Daniels; Bimmi Shrestha; Jose L Proenca-Modena; Erin D Lew; Helen M Lazear; Matthew J Gorman; Greg Lemke; Robyn S Klein; Michael S Diamond
Journal:  Nat Med       Date:  2015-11-02       Impact factor: 53.440

Review 10.  Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis.

Authors:  Hamid Salimi; Matthew D Cain; Robyn S Klein
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

View more
  24 in total

1.  Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.

Authors:  Aaron W Walters; Michael R Kujawa; Joseph R Albe; Douglas S Reed; William B Klimstra; Amy L Hartman
Journal:  Virology       Date:  2018-11-02       Impact factor: 3.616

2.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

Review 3.  Neuroinflammation During RNA Viral Infections.

Authors:  Robyn S Klein; Charise Garber; Kristen E Funk; Hamid Salimi; Allison Soung; Marlene Kanmogne; Sindhu Manivasagam; Shannon Agner; Matthew Cain
Journal:  Annu Rev Immunol       Date:  2019-04-26       Impact factor: 28.527

4.  Evaluation of the Incidence of Other Cranial Neuropathies in Patients With Postviral Olfactory Loss.

Authors:  Kawinyarat Jitaroon; Yossawee Wangworawut; Yifei Ma; Zara M Patel
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

Review 5.  Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.

Authors:  Carmela Conte
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

6.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

7.  Therapeutic enhancement of blood-brain and blood-tumor barriers permeability by laser interstitial thermal therapy.

Authors:  Afshin Salehi; Mounica R Paturu; Bhuvic Patel; Matthew D Cain; Tatenda Mahlokozera; Alicia B Yang; Tsen-Hsuan Lin; Eric C Leuthardt; Hiroko Yano; Sheng-Kwei Song; Robyn S Klein; Robert Schmidt; Albert H Kim
Journal:  Neurooncol Adv       Date:  2020-06-30

8.  Infection-Induced Systemic Inflammation Is a Potential Driver of Alzheimer's Disease Progression.

Authors:  Vijayasree V Giridharan; Faisal Masud; Fabricia Petronilho; Felipe Dal-Pizzol; Tatiana Barichello
Journal:  Front Aging Neurosci       Date:  2019-05-28       Impact factor: 5.750

Review 9.  Genetic control of alphavirus pathogenesis.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Mamm Genome       Date:  2018-08-27       Impact factor: 2.957

10.  Direct and indirect pro-inflammatory cytokine response resulting from TC-83 infection of glial cells.

Authors:  Forrest Keck; Stephanie Kortchak; Allison Bakovic; Brian Roberts; Nitin Agrawal; Aarthi Narayanan
Journal:  Virulence       Date:  2018       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.